Thus, acral melanomas show enrichment in Crk-like protein (CRKL) amplification, that in cooperation with transcriptional programs expressed in specific anatomical locations, such as the limbs, lead to the amplification of insulin-like growth factor (IGF) signaling by interfering with the PI3K pathway downstream the IGF signaling itself. This evidence concerns the gene CRKL and acral lentiginous melanoma.